ALIM

Alimera Sciences, Inc.

3.28 USD
-0.09 (-2.67%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Alimera Sciences, Inc. stock is down -16.33% since 30 days ago. The next earnings date is Apr 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 64.29% of the previous 13 February’s closed higher than January.

About Alimera Sciences, Inc.

Alimera Sciences, Inc. offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME) The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.